Antiphospholipid antibodies in pregnant women with preeclampsia: a case control study

AJBM crossMark

Ekhlas Jabbar kadhim¹ ⃰, Raya Khalid Salih², Wasan Mahmood Abed², Maysoon Mohammad Jabir²*


Preeclampsia is a major cause of maternal morbidity and mortality, complicating 3-14% of all pregnancies. Pregnancy complicated by antiphospholipid antibodies and preeclampsia in pregnancy share several common characteristics, which suggest that the association between the two conditions is more than coincidental. To assess the level of antiphospholipid antibodies in normal pregnancy and in pregnancy complicated by preeclampsia a case control prospective study carried out in Department of Obstetrics and Gynecology/Baghdad Teaching Hospital/ Medical City/ from January 2012 to January 2013. Seventy-two pregnant women were enrolled into this study, 48 with preeclampsia (mild and severe), and 24 women without hypertension as a control group. Their age ranges from (16-42 years) and gestational age between (24-40 weeks). Antiphospholipid antibodies APLAB (IgG and IgM) and anticardiolipin antibodies ACLAB (IgG and IgM) levels were measured by ELISA (enzyme. linked Immuno- Sorbent Assay) in all participates. The study showed elevation of ACLAB IgM in preeclampsia group with mean ±SD of (21.93±16.12), (8.22±1.75) for severe and mild preeclampsia respectively while in the control group it was (6.62± 2.8). This was highly significant in severe preeclampsia when compared to mild and control group. We conclude that there is significantly elevated level of ACLAB IgM in severe preeclampsia when compared to normal pregnancy.

Keywords: Preeclampsia; Antiphospholipid antibodies; Anticardiolipin; Pregnancy

Copyright © 2017 by The American Society for BioMedicine and BM-Publisher, Inc.

Article citationReferencesFull-Text/PDFFeedback
The citation data is computed by the following citation measuring services:

Cited by (CrossRef)
Google Scholar


PDF Open Access

For any technique error please contact us and will be response to sending purchase article by email.

Who Can Become a Reviewer?
Any expert in the article's research field can become a reviewer with American Journal of Biomedicine. Editors might ask you to look at a specific aspect of an article,...

Find out more

Thank you for visiting American Journal of BioMedicine. * = Required fields

Error: Contact form not found.

Case Report
American Journal of BioMedicine Volume 5, Issue 7, pages 348-355
Received March 02, 2017; accepted June 28, 2017; published July 12, 2017